D458
ターミナリアベリリカタブレットＮ
株式会社東洋新薬販売休止中
加工食品(錠剤、カプセル剤等)
Category
Notif. Date
2019-01-16
Planned Sale Date
Functional Claim
本品には、ターミナリアベリリカ由来没食子酸が含まれるので、肥満気味な方の内臓脂肪（おなかの脂肪）とBMIを減らすのを助ける機能があります。
Functional Ingredient
Content
Functional Claim
本品には、ターミナリアベリリカ由来没食子酸が含まれるので、肥満気味な方の内臓脂肪（おなかの脂肪）とBMIを減らすのを助ける機能があります。
AI Summary
Automatically generated from notification documents
This functional food contains gallic acid derived from Terminalia bellirica and has been reported to help reduce visceral fat and BMI in individuals with mild obesity.
Key Features
[
"
V
i
s
c
e
r
a
l
f
a
t
s
u
p
p
o
r
t
"
,
"
B
M
I
m
a
n
a
g
e
m
e
n
t
"
,
"
P
l
a
n
t
-
d
e
r
i
v
e
d
i
n
g
r
e
d
i
e
n
t
s
"
]
Adults with mild obesity aiming to reduce visceral fat and BMI.
Recommended ProductsPR
広告: A8.net
Notification Documents
| Product Name | ターミナリアベリリカタブレットＮ |
| Category | |
| Food Classification | 加工食品(錠剤、カプセル剤等) |
| Functional Ingredient Name | ターミナリアベリリカ由来没食子酸 |
| Functional ingredient is an extract | No |
| Functional Claim | 本品には、ターミナリアベリリカ由来没食子酸が含まれるので、肥満気味な方の内臓脂肪（おなかの脂肪）とBMIを減らすのを助ける機能があります。 |
| Consumer Affairs Department Contact | |
| Information Disclosure Website URL |
| (1) Precautions for Intake | |
| (2) Safety Evaluation Method | |
| (3) Notifier's Safety Evaluation |
| Details |
| (1) Functionality Evaluation Method | |
| (2) Notifier's Functionality Evaluation |
| Reason for not classifying as tablet/capsule food | |
| Primary Target Audience | |
| Planned Sales Start Date | |
| Change History (before Mar 31, 2025) | |
| Change History (from Apr 1, 2025) | |
| Before/After Comparison Table | |
| Before/After Comparison Table (attachments) | |
| If re-notification | No |
| Existing Notification Number | |
| Reason for Maintaining Identity | |
| Post-notification Sales Status | 販売休止中 |
| Reason for Notification Withdrawal |
| Month of Last Self-Inspection Report |